Annual Report for the Financial Year 2025-2026 of the Company.

VIVANZA BIOSCIENCES LIMITED Regd. Office: 403, Sarthik 2, Opp. Rajpath Club, S. G. Highway, Ahmedabad 380054. Phone: 079-26870953, email: info@vivanzabiosciences.com, website: www.vivanzabiosciences.com CIN: L24105GJ1982PLC005057 Date: 19th August, 2026 Department of Corporate Services, BSE Limited, Ground Floor, P. J. Towers, Dalal Street, Mumbai – 400001, Scrip Code: 530057 ISIN: INE984E01035 Subject: Notice of the 44th Annual General Meeting ('AGM') and Annual Report of the Company for the Financial Year 2025-26 Dear Sir/Madam, We wish to inform you that 44th AGM of the Company is scheduled to be held on Friday, September 11, 2026, at 03:30 P.M. (IST) through Video Conference/Other Audio Visual Means. Pursuant to Regulation 34 and Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), please find enclosed the Notice of the 44th AGM and Annual Report of the Company which are being sent in electronic mode to the shareholders of the Company whose e-mail addresses are registered with the Company/ Registrar & Share Transfer Agent/ Depositories. For those shareholders who have not registered their email addresses, a letter providing the weblink from which the Notice of the 44th AGM and Annual Report for the financial year 2025-26 can be accessed is being sent. The Notice will also be made available on the Company’s website at www.vivanzabiosciences.com. We request you to take the same on record. Thanking you For Vivanza Biosciences Limited JAYENDRA MEHTA MANAGING DIRECTOR DIN: 08210602 REHYDRAZEN Vivanza Biosciences Limited I Annual Report 2025-2026 INSIDE DETAILS INDEX Sr No. Contents Page No. 1 Corporate information 4 2 Notice of 44thAnnual General Meeting and Annexure to the Notice 5 3 Director’s Report for the year ended 31st March, 2026 24 4 Form No. AOC- 1 (Annexure - A to the Director’s Report) 34 5 Form No. AOC- 2 (Annexure - B to the Director’s Report) 35 Disclosures under Para A of Schedule V of Listing Regulations (Annexure - C to the 6 36 Director’s Report) Details pertaining to remuneration of Directors and KMP (Annexure - D to the 7 37 Directors Report) Form No. MR-3 Secretarial Audit Report for the financial year ended 31st March, 8 39 2025 (Annexure - E to the Director’s Report) Non- Applicability of Corporate Governance Report (Annexure -F to the Director’s 9 43 Report) Management Discussion and Analysis Report (Annexure - G to the Director’s 10 44 Report) 11 Independent Auditor’s Report (Standalone) 46 12 Financial of the Company (Standalone) 55 13 Independent Auditor’s Report (Consolidated) 80 14 Financial of the Company (Consolidated) 86 CORPORATE INFORMATION BOARD OF DIRECTORS Mr. Jayendra A. Mehta : Managing Director Mr. Sarang B. Pathak : Non Executive Non Independent Director (Appointed w.e.f. 30.08.2025) Mr. Parikh H. A. : Non Executive Non Independent Additional Director (Appointed w.e.f. 18.06.2026) Ms. Rina Kumari : Independent Director Mr. Hitesh Rijwani : Independent Director (Appointed w.e.f 12.05.2025) KEY MANAGERIAL PERSONNEL Mr. Jainil R. Bhatt : Chief Financial Officer Mr. Chaitra Arora : Company Secretary (Resigned w.e.f 30.04.2026) Mr. Vishal Katarmal : Company Secretary (appointed w.e.f 08.07.2026) AUDITOR Shivam Soni & Co. Chartered Accountants Ahmedabad SECRETARIAL AUDITOR M/s. Chintan Patel & Associates, Practicing Company Secretary Ahmedabad. REGISTERED OFFICE 403/TF, Sarthik II, Opp. Rajpath Club, S.G Highway, Bodakdev, Ahmedabad CIN:L24105GJ1982PLC005057 Email: info@vivanzabiosciences.com Website: www.vivanzabiosciences.com REGISTRAR & SHARE TRANSFER AGENTS Purva Sharegistry (India) Pvt. Ltd. Shiv Shakti Industrial Estates, Unit No. 9 J. R. Boricha Marg, Opp. Kasturba Hospital Lane Lower Parel (E), Mumbai –400011 Email: support@purvashare.com STOCK CODE BSE: 530057 ISIN: INE984E01035 NOTICE Notice is hereby given that the 44th Annual General Meeting of the Shareholders of Vivanza Biosciences Limitedwill be held on Friday, 11th September, 2026 at 03:30 P.M. through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) to transact the following business. The venue of the meeting shall be deemed to be the registered office of the Company at 403, Sarthik 2, Opp. Rajpath Club, S.G Highway, Ahmedabad- 380054, Gujarat, India ORDINARY BUSINESS: 1. ADOPTION OF AUDITED STANDALONE AND CONSOLIDATED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31ST, 2026 TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND INDEPENDENT AUDITOR’S REPORTS THEREON. To consider and, if thought fit, to pass with or without modification(s), the following Resolution as an Ordinary Resolution. “RESOLVED THAT: a. The Audited Standalone Financial Statements of the Company for the Financial Year ended on 31st March, 2026 and reports of the Board of Directors and Independent Auditor’s report thereon laid before this meeting, be and is hereby considered and adopted. b. The Audited Consolidated Financial Statements of the Company for the Financial Year ended on 31st March, 2026 and reports of Board of Directors and Independent Auditor’s report thereon laid before this meeting, be and is hereby considered and adopted. 2. TO APPOINT A DIRECTOR IN PLACE OF MR. JAYENDRA MEHTA (DIN: 08210602) WHO RETIRES BY ROTATION AND BEING ELIGIBLE, OFFERS HIMSELF FOR RE-APPOINTMENT. To consider, and if thought fit to pass the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 152 and all other applicable provisions of the Companies Act, 2013 read with Rules framed thereunder (including any statutory modification(s) or re- enactment(s) thereof for the time being in force), Mr. Jayendra A. Mehta (DIN: 08210602), Director, who retires by rotation at this 44th Annual General Meeting, and being eligible for re-appointment, be and is hereby re-appointed as a Director of the Company, liable to retire by rotation.” SPECIAL BUSINESS: 3. TO APPROVE REGULARIZATION OF ADDITIONAL DIRECTOR MR. H.A PARIKH (DIN: 00027820) AS A NON-EXECUTIVE NON-INDEPENDENT DIRECTOR OF THE COMPANY. To consider and if thought fit, to pass with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT, pursuant to the provisions of Section 149, 152, 160 and all other provisions of the Companies Act, 2013 and the Companies (Appointment and Qualifications of Directors) Rules, 2014, [including any statutory modification(s) or re-enactment(s) thereof for the time being in force] and Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), and other applicable laws Mr. H.A Parikh (DIN: 00027820), who was appointed as an Additional Director of the Company With effect from 18th June, 2026 by the Board of Directors pursuant to Section 161 of the Companies Act, 2013 and as recommended by Nomination & Remuneration Committee and who holds office only upto Annual General Meeting to be held on September 11th, 2026 and for appointment of whom Notice under Rule 13 of Companies (Appointment and Qualifications of Directors) Rules, 2014 proposing his candidature for the office of Director has been received, be and is hereby appointed as Non-Executive, Non- Independent Director, whose period of office will be liable to determination by Retirement of directors Rotation.” “RESOLVED FURTHER THAT, the Board of Directors of the Company be and is hereby authorized to do all such acts, deeds, matters and things as may be considered necessary, desirable or expedient to give effect to this resolution.” 4. TO APPROVE THE MATERIAL RELATED PARTY TRANSACTION(S) PROPOSED TO BE ENTERED INTO BY THE COMPANY DURING THE FINANCIAL YEAR 2026-2027. To consider and if thought fit, to pass with or without modification(s), the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 188 and other applicable provisions, if any of the Companies Ac [Showing first 8,000 characters — download PDF for full document]